Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 837.84 T ARS | 17.000 USD | +2.41% | 312 | 1.13 | 228.06 | 106.49 ARS | −7.58% | 0.35% | Health technology | — |
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 837.84 T ARS | 19,975.000 ARS | +0.25% | 3.308 K | 1.11 | 187.58 | 106.49 ARS | +362.10% | 0.35% | Health technology | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 382.237 T ARS | 11.350 USD | 0.00% | 299 | 0.31 | 58.18 | 278.68 ARS | −6.49% | 1.20% | Health technology | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 382.237 T ARS | 1,600.000 ARS | 0.00% | 57 | 6.00 | — | — | — | — | Health technology | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 382.237 T ARS | 13,375.000 ARS | −2.01% | 6.289 K | 0.63 | 47.99 | 278.68 ARS | +367.55% | 1.20% | Health technology | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 329.479 T ARS | 19.300 USD | −0.26% | 23 | 0.61 | 15.04 | 1,832.68 ARS | −55.07% | 1.30% | Health technology | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 329.479 T ARS | 23,550.000 ARS | −0.95% | 482 | 1.03 | 12.85 | 1,832.68 ARS | +124.67% | 1.30% | Health technology | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 286.277 T ARS | 23.600 USD | −4.65% | 10 | 2.63 | 43.99 | 766.45 ARS | +2,362.86% | 1.00% | Health technology | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 286.277 T ARS | 28,525.000 ARS | −2.56% | 1.098 K | 0.54 | 37.22 | 766.45 ARS | +12,214.28% | 1.00% | Health technology | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 235.968 T ARS | 40.200 USD | −0.74% | 68 | 17.89 | 102.39 | 560.88 ARS | −23.30% | 1.19% | Health technology | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 235.968 T ARS | 48,175.000 ARS | −0.82% | 266 | 0.17 | 85.89 | 560.88 ARS | +283.52% | 1.19% | Health technology | — |
NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 221.562 T ARS | 28.550 USD | +0.53% | 1 | 0.36 | 3.68 | 11,077.40 ARS | +107.32% | 3.35% | Health technology | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 221.562 T ARS | 35,375.000 ARS | −1.46% | 39 | 0.07 | 3.19 | 11,077.40 ARS | +936.61% | 3.35% | Health technology | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 161.921 T ARS | 7.600 USD | −0.65% | 1.796 K | 1.62 | 637.35 | 17.03 ARS | −97.83% | 2.79% | Health technology | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 161.921 T ARS | 9,020.000 ARS | −1.85% | 12.454 K | 0.58 | 529.50 | 17.03 ARS | −89.14% | 2.79% | Health technology | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 95.745 T ARS | 20,000.000 ARS | −2.44% | 598 | 1.32 | — | −4,655.71 ARS | −533.79% | 4.83% | Health technology | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 82.16 T ARS | 12,675.000 ARS | −2.69% | 63 | 0.27 | 32.74 | 387.18 ARS | +14.97% | 2.12% | Health technology | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 28.268 T ARS | 15.000 USD | −7.69% | 9 | 0.84 | 43.57 | 491.84 ARS | −59.29% | 0.00% | Health technology | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 28.268 T ARS | 18,825.000 ARS | 0.00% | 406 | 1.95 | 38.27 | 491.84 ARS | +103.55% | 0.00% | Health technology | — |
RICHLABORATORIOS RICHMOND SACIF | 73.242 B ARS | 907.000 ARS | −0.44% | 9.674 K | 1.14 | 409.67 | 2.21 ARS | — | 0.00% | Health technology | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5.28 B ARS | 124.000 ARS | +0.61% | 62.086 K | 5.14 | 9.38 | 13.22 ARS | — | 0.00% | Health technology | — |